SARS-CoV-2 related pneumonia in an adult with cystic fibrosis: natural favourable clinical course or effective therapy?
Monaldi Arch Chest Dis
; 90(4)2020 Dec 23.
Artículo
en Inglés
| MEDLINE | ID: covidwho-1042105
ABSTRACT
We report the case of a man affected by cystic fibrosis who developed a severe SARS-CoV-2 related pneumonia in March 2020. In addition to lopinavir/ritonavir and hydroxychloroquine, he was treated with two doses of tocilizumab, displaying a significant clinical improvement. This is the first case described in the literature of an adult patient affected by cystic fibrosis who received tocilizumab for COVID-19, with documented total recovery, also assessed by a spirometry.
Texto completo:
Disponible
Colección:
Bases de datos internacionales
Base de datos:
MEDLINE
Asunto principal:
Neumonía Viral
/
Infecciones del Sistema Respiratorio
/
Ritonavir
/
Fibrosis Quística
/
Lopinavir
/
Anticuerpos Monoclonales Humanizados
/
SARS-CoV-2
/
COVID-19
/
Tratamiento Farmacológico de COVID-19
/
Hidroxicloroquina
Tipo de estudio:
Reporte de caso
/
Estudios diagnósticos
/
Estudio experimental
/
Estudio pronóstico
Tópicos:
Covid persistente
/
Vacunas
Límite:
Adulto
/
Humanos
/
Masculino
Idioma:
Inglés
Año:
2020
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS